Status: Recruiting
Psilocybin in Cancer Pain Study
The overall objective of this study is to assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy to alleviate opioid-refractory pain in patients with advanced-cancer. The name of the study intervention used in this research study is: Psilocybin (a tryptamine derivative)
Participants needed: 15
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Yvan Beaussant, MD, MSciUpdated: Dec 16, 2025Locations: 1
Eligibility criteria
Participants must be 18 year old or older; [+16]
Participants who receive concurrent (less than four weeks or planned within 6 we... [+29]